Join fme at the Pharmaceutical Manufacturing World Summit
Every year, the Pharmaceutical Manufacturing World Summit in Boston brings together industry leaders, innovators, and manufacturing experts to explore the future of pharmaceutical production. As both attendees and sponsors, the fme team enjoys this unique opportunity to engage in meaningful conversations, exchange insights, and advise on the technology and data management strategies that shape Life Sciences manufacturing today. Many of the key themes that defined last year’s agenda continue to be critical topics within the industry.
Key Themes Shaping Pharmaceutical Manufacturing World Summit
Year after year, one common thread unifies the agenda: Data is the foundation of transformation for business success.
Whether enabling AI, supporting regulatory compliance, or driving operational efficiency, success depends on having trusted, structured, and accessible data across the product lifecycle. Here are some of the recent areas of focus we’ve repeatedly shared with our clients:
Data as a Strategic Asset
One of the most important points of the conference is data is no longer just operational, it’s transformational. Organizations are increasingly relying on high-quality, accessible data to drive decision-making across supply chains, manufacturing performance, and patient safety.
The ability to treat data as a strategic asset rather than a byproduct has finally been recognized as a competitive differentiator, and has been fme’s focus and mission for over 25 years. We help companies maximize the value and power of their data, ensuring it is structured, reusable, and ready to migrate into powerful solutions that unlock its full value across the enterprise.
Navigating Geopolitical Uncertainty
Global manufacturing strategies are being reshaped by shifting regulatory landscapes, trade policies, and geopolitical tensions. From increased pressure to localize production in the U.S. to evolving FDA leadership and AI regulation, companies are operating in an environment of heightened uncertainty and risk.
fme helps guide organizations through the dynamic data management challenges that can affect supply chain resilience, inspection readiness, and compliance strategies.
Infrastructure Investment and Digital Transformation
The scale of investment in modern manufacturing infrastructure is staggering. Leading pharmaceutical companies are building digitally native, highly automated facilities designed for flexibility, speed, and advanced modalities like cell and gene therapies.
Technologies such as digital twins, robotics, IIoT, and integrated MES/QMS platforms are becoming foundational. At the same time, organizations are recognizing that less than 1% of process data is often fully utilized, highlighting a major opportunity for transformation.
To ensure technology investments address both immediate and long-term needs, it is critical to work with a technology partner that understands the technical and business goals of an integrated research, development, and manufacturing pipeline.
Pricing Pressures Driving Efficiency
With rising costs across the industry, manufacturers are under pressure to do more with less. The focus has shifted toward reducing inefficiencies, eliminating rework, and accelerating system consolidation.
This is where digital enablement and automation powered by clean, high-integrity data are playing a critical role in turning compliance into a value-generating function rather than a cost center.
Innovation Accelerating at Scale
From AI-driven quality transformation to novel manufacturing platforms, innovation is rapidly reshaping the industry.
Highlights from last year included:
- AI-enabled quality systems and predictive manufacturing
- Expansion into advanced modalities like ADCs and cell therapies
- End-to-end digital supply chain orchestration
- Increasing use of GenAI to enhance quality and operational efficiency
Organizations are not just experimenting. They are scaling these innovations to drive measurable business outcomes before their competition.
Join Us at This Year’s Summit
We’re excited to return to the Pharmaceutical Manufacturing World Summit this year as a sponsor and continue the conversation with industry leaders.
If you’ll be attending, we’d love to connect! Contact us and we’ll schedule a time to discuss your current challenges, share our proven strategies and insights, or explore how to accelerate your digital and data initiatives. If you can’t attend and would like a summary of the essential topics and sessions, let us know.
fme AG
fme SRL


Matthew Peterson
